Jared R. Auclair is currently the Director of Executive Training and Biotechnology Programs in the department of chemistry and chemical biology at Northeastern University. In addition to being Director of Biotechnology, Dr. Auclair also directs the Biopharmaceutical Analysis Training Laboratory, the Asia-Pacific Economic Cooperation Center of Regulatory Excellence in Biotherapeutics and oversees the International Council for Harmonisation training. These appointments allow Dr. Auclair to collaborate with both academic researchers and industry in the area of biopharmaceutical development and analysis, as well as international regulators on best practices and new advances in the regulatory sciences for drug approvals.
Prior to joining Northeastern, Dr. Auclair received his bachelor’s degree in biotechnology from Worcester Polytechnic Institute and a PhD in Biomedical Science from the University of Massachusetts Medical. In both of instances, Dr. Auclair’s research focused on understanding the molecular mechanism of HIV-1. Upon graduating with his PhD, he did a post-doc under Greg Petsko, Dagmar Ringe and Jeffrey Agar at Brandeis University. Here Dr. Auclair used protein biochemistry, protein crystallography and protein mass spectrometry to study the molecular mechanism of Amyotrophic Lateral Sclerosis. Currently, Dr. Auclair’s uses his expertise in Analytical Biochemistry to address topics as broad as protein chemistry, lipid biology, proteomics, and metabolomics.